Laserfiche WebLink
58052 Federal Register / Vol , 80, No . 186 / Fridays September 25 , 2015 / Proposed Rules <br /> practice and either have one inch or less containers that once held regulations of § 261 . 7 apply to all sizes <br /> of residue remaining , or 3 percent or pharmaceuticals that are RCRA of containers , they were developed with <br /> less of weight of the total capacity of the hazardous wastes . We are proposing larger, industrial-sized containers in <br /> container remaining, then the container different regulatory solutions for mind. For the most part, the containers <br /> is considered " RCRA empty , " and may different types of containers found in that hold pharmaceuticals range in size <br /> be managed as non-hazardous waste. healthcare settings . Specifically , we from a few milliliters (e.g. , packaging for <br /> Likewise, according to § 261 , 7(b) (3) , address the following three types of nicotine gum , paper cups used to <br /> there are three ways that a container containers : (1 ) Unit-dose containers dispense pharmaceuticals to in-patients) <br /> that held an acute hazardous waste can (e.g„ packets , cups, wrappers , blister to a liter (e.g., bottles that hold bulk <br /> be considered " empty packs , and delivery devices) and quantities of pills), In rare <br /> A container or an inner liner removed dispensing bottles and vials ; (2) circumstances , containers with <br /> from a container that has held an acute dispensed syringes; and (3) other pharmaceuticals are as large as two or <br /> hazardous waste listed in §§ 261 . 31 or containers , including delivery devices . three liters (e .g., powders that are <br /> 261 . 33(e) is "empty" if: If finalized, these new regulations for reconstituted with water) . This differs <br /> ( i ) The container or inner liner has pharmaceutical containers would significantly from the 55-gallon drums <br /> been triple rinsed using a solvent replace the November 2011 guidance; that are typically used in other sectors <br /> capable of removing the commercial however, in the meantime , the guidance that generate hazardous waste. <br /> chemical product or manufacturing remains in effect . Consequently , the amount of residues in <br /> chemical intermediate; b. Unit-dose containers. First , with the containers was anticipated to be <br /> (ii ) The container or inner liner has regard to unit-dose containers and much more substantial than is the case <br /> been cleaned by another method that dispensing bottles and vials up to 1 liter for containers typically used for <br /> has been shown in the scientific or 1000 pills , we are proposing a pharmaceuticals . <br /> literature , or by tests conducted by the conditional exemption from the empty <br /> generator, to achieve equivalent container regulations of § 261 . 7 for EPA has received data from three <br /> removal ; or containers from which the stakeholders demonstrating that there is <br /> (iii) In the case of a container, the pharmaceuticals have been fully very little residue remaining in fully <br /> inner liner that prevented contact of the dispensed . Specifically, we are dispensed containers of <br /> commercial chemical product or proposing that the removal of the pharmaceuticals . In addition , EPA's <br /> manufacturing chemical intermediate pharmaceuticals from the unit-dose ORD conducted similar research . The <br /> with the container, has been removed, containers, and dispensing bottles and results from each of the four sources are <br /> Therefore , if the container that held vials (up to 1 liter or 1000 pills) , is summarized below ; the full results are <br /> the P-listed pharmaceutical is not triple equivalent to rendering the container included in the docket for this proposed <br /> rinsed , or cleaned by another method "RCRA empty. " Therefore , for rulemaking (EPA–HQ–RCRA-2007– <br /> that has been demonstrated to achieve containers that once held non-acute 0932 ) a <br /> equivalent removal , or had the inner hazardous wastes , it will not be i , Consulting Firm . One stakeholder, <br /> liner removed , the container is not necessary to measure the remaining with a hazardous medical materials <br /> considered " RCRA empty , " even though contents , and for containers that once consulting firm, provided some <br /> the pharmaceutical may have been fully held acute hazardous wastes , it will not laboratory testing. They had the <br /> dispensed. If the container is not "RCRA be necessary to triple-rinse the residues from single unit dose <br /> empty , " then the residues are regulated containers or demonstrate an equivalent packaging of four different P-listed <br /> as acute hazardous waste. removal method. Rather , if the contents pharmaceuticals tested using gas <br /> In November 2011 , EPA issued of the container have been fully chromatography/mass spectrometry <br /> guidance about containers that once dispensed by removing all (GC/MS) and high performance liquid <br /> held P-listed pharmaceuticals 1211 that pharmaceuticals that can be removed chromatography/ultraviolet detector <br /> provides three possible regulatory using the practices commonly employed <br /> p p g � to remove materials from that type of (HPLC/UV) . The amount of active <br /> ap roaches for generatorsv harmaceutical ingredient in the <br /> r1 ) Count only the weight of the container, the residues (and therefore residues remaining in containers was <br /> residue toward generator category the container) may be disposed of as quantified and the results from <br /> ( 2) Demonstrate an equivalent non-hazardous waste . containers that had been triple rinsed <br /> removal method to render containers We are proposing this conditional were compared with containers that had <br /> RCRA empty exemption for two reasons . First , we P <br /> not been triple rinsed . For the <br /> ( 3 ) In the case of warfarin , show that want to eliminate the sewering of <br /> containers that were triple rinsed , the <br /> the concentration in the residue is pharmaceuticals . We are particularly <br /> below the P-listed concentration . concerned that in a healthcare setting , active ingredient in the residues was <br /> This guidance was intended as a when containers are triple rinsed, the non-detect in all cases . For the <br /> short-term solution that worked within rinsate will be poured down the drain containers that were not triple rinsed , <br /> gg <br /> the confines of the existing RCRA which is not a good environmental the highest leve( detected was res is <br /> hazardous waste regulations and EPA practice. We think it is important that (or 0. 0358 mg). The laboratory results <br /> indicated at the time that a more the residues be managed in a more submitted to EPA are summarized in <br /> comprehensive solution would require controlled manner such as municipal Table 9 ; the full laboratory results are <br /> notice and public comment that occurs solid waste management—rather than included in the docket for this <br /> during a rulemaking. We are proposing poured down the drain. Second , rulemaking (EPA�HQ–RCRA--2007– <br /> to amend the regulations that pertain to although the "empty container" 0932) . <br /> 129 Rudzinski to RCRA Division Directors, yosemitr, .epo.gov/osw/rcra. nsf/ 57821 r2rE33735128525795r66610roNsfile/ <br /> November tl , 2011 , RCRA Online #14827 http:// 6c994248c239947e85256dt196671175f/ 14827.pdf. <br />